Micromeritic studies on nicardipine hydrchloride microcapsules

International Journal of Pharmaceutics

Volumn 138, Issue 1, 1996, Pages 25-35

  Özyazici, Mine ^a   Sevgi, Ferhan ^a   Ertan, Gökhan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Drug content of gelatin capsules; Microcapsule; Micromeritic properties; Nicardipine hydrochloride; Particle population analysis; Scanning electron microscopic studies

Indexed keywords

NICARDIPINE;

ARTICLE; DENSITY; DRUG COATING; DRUG DOSAGE FORM; MICROCAPSULE; MICROENCAPSULATION; PARTICLE SIZE; PHYSICAL PHENOMENA; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

EID: 0030581129     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04516-4     Document Type: Article

References (45)

1. Baky, S.H., Nicardipine hydrochloride. New Drugs Annual: Cardiovascular Drugs, Vol. 3, Raven Press, New York, 1985, pp. 153-172.
2. Barber, T.A., Pharmaceutical Paniculate Matter: Analysis and Control, Interpharm Press Inc., New York, 1993, pp. 266-349.
3. Bonferoni, M.C., Mellerio, G., Giunchedi, P., Caramella, C. and Conte, U., Photostability evaluation of nicardipine HCl solution. Int. J. Pharm., 80 (1992) 109-117.
4. Carstensen, J.T. and Chan, P.C., Flow rates and repose angles of wet-processed granulations. J. Pharm. Sci., 66 (1977) 1235-1238.
5. Carstensen, J.T. and Musa, M.N., Dissolution rate patterns of log-normally distributed powders. J. Pharm. Sci., 61 (1972) 223-227.
6. Chukwu, A., Agarwal, S.P. and Adikwu, M.U., Some properties of chloroquine phosphate and quinine hydrochloride microcapsules. Stp Pharma Sci., 1 (1991) 117-120.
7. Eaves, T. and Jones, T.M., Effect of moisture on tensile strength of bulk solids I: sodium chloride and effect of particle size. J. Pharm. Sci., 61 (1972) 256-261.
8. Ertan, G., Sangüllü, I. and Güneri, T., Micromeritic properties of nitrofurantoin microcapsules. Drug Dev. Ind. Pharm., 21 (1995) 1323-1328.
9. Fassihi, A.R. and Kanfer, I., The effect of compressibility and powder flow properties on tablet weight variation. In: Rubinstein, M.H. (Ed.), Pharmaceutical Technology, Tableting Technology, Vol. 1, Wiley, New York, 1987, pp. 189-202.
10. Fonner, D.E., Jr., Banker, G.S. and Swarbrick, J., Micromentics of granuler pharmaceutical granules. J. Pharm. Sci., 55 (1966a) 576-580.
11. Fonner, D.E., Jr., Banker, G.S. and Swarbrick, J., Micromeritics of granuler pharmaceutical solids I: physical properties of particles prepared by five different granulation methods. J. Pharm. Sci., 55 (1966b) 181-186.
12. Gold, G., Duvall, R.N. and Palermo, B.T., Powder flow studies I: instrumentation and applications. J. Pharm. Sci., 55 (1966a) 1133-1136.
13. Gold, G., Duvall, R.N., Palermo, B.T. and Slatere, J.G., Powder flow studies II: effect of glidants on flow rate and angle of repose. J. Pharm. Sci., 55 (1966b) 1291-1295.
14. Guerret, M., Cheymol, G., Hubert, M., Julien-Larose, C. and Lavene, D., Simultaneous study of pharmacokinetics of intravenous and oral nicardipine using a stable isotope. Eur. J. Clin. Pharmacol., 37 (1989) 381-385.
15. Güclüyildiz, H., Banker, G.S. and Peck, G.E., Determination of porosity and pore-size distribution of aspirin tablets relevant to drug stability. J. Pharm. Sci., 66 (1977) 407-414.
16. Güven, K.C., Eczacihk Teknolojisi, Modern Röprodüksiyon, Istanbul, 1987, pp. 272-273.
17. Hajratwala, B.R., Particle size reduction by a hammer mill I: effect of output screen size, feed particle size, and mill speed. J. Pharm. Sci., 71 (1982) 188-190.
18. Hiestand, E.N., Powders: particle-particle interactions. J. Pharm. Sci., 55 (1966) 1325-1344.
19. Ismail, S.I. and Tawashi, R., Size distribution characteristics of mineral phase in renal stones. J. Pharm. Sci., 69 (1980) 829-831.
20. Jalsenjak, I. and Kondo, T., Effect of capsule size on permeability of gelatin-acacia microcapsules toward sodium chloride. J. Pharm. Sci., 70 (1981) 456-457.
21. Jalsenjak, I., Nicolaidou, C.F. and Nixon, J.R., The in vitro dissolution of phenobarbitone sodium from ethylcellulose microcapsules. J. Pharm. Pharmacol., 28 (1976) 912-914.
22. Kawashima, Y., Matsuda, K. and Takenaka, H., Physicochemical properties of spray-dried agglomerated particles of salicylic acid and sodium salicylate. J. Pharm. Pharmacol., 24 (1972) 505-512.
23. Kawashima, Y., Niwa, T., Handa, T., Takeuchi, H., Iwamoto, T. and Itoh, K., Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. J. Pharm. Sci., 78 (1989) 68-72.
24. Martin, A.N., Swarbrick, J. and Cammarata, A., Micromeritics. In: Physical Pharmacy, 2nd edn., Lea and Febiger, Philadelphia, PA, 1969, pp. 467-496.
25. Messhali, M.M., El-Dein, E.Z., Omar, S.A. and Luzzi, L.A., Effect of pectin and rutin on the physicochemical properties of certain nonsteroidal anti-inflammatory drugs. Acta Pharm. Fenn., 100 (1991) 219-228.
26. Morris, N.J. and Warburton, B., Three-ply walled w/o/w microcapsules formed by a multiple emulsion technique. J. Pharm. Pharmacol., 34 (1982) 475-479.
27. Münzel, K., Büchi, J. and Schultz, O.E., Einfache und gemischte Pulver. In: Galenisches Praktikum, Wissenschaftliche Verlagsgescellschaft MBH, Stuttgart, 1959, pp. 685-712.
28. Nixon, J.R. and Hassan, M., The effect of preparative technique on the particle size of thiabendazole microcapsules. J. Pharm. Pharmacol., 32 (1980a) 856-857.
29. Nixon, J.R. and Hassan, M., The effect of tableting on the dissolution behaviour of thiabendazole microcapsules. J. Pharm. Pharmacol., 32 (1980b) 857-859.
30. Podczeck, F., Merkel, G. and Révész, P., The application of canonical analysis to the evaluation of the influence of changes in components of standard direct compression tablet formulations. Int. J. Pharm., 97 (1993) 15-28.
31. Rubinstein, M.H. and Blane, M.C., The effect of granule size on the in vitro and in vivo properties of bendroflazide tablets 5 mg. Pharm. Acta Helv., 52 (1977) 5-10.
32. Salib, N.N., El-Menshawy, M.E. and Ismail, A.A., Ethylcellulose as a potential sustained release coating for oral pharmaceuticals. Pharmazie, 31 (1976) 721-723.
33. Schwartz, J.B., Log-normal distribution of tablet pore diameters. J. Pharm. Sci., 63 (1974) 774-776.
34. Senjkovic. R. and Jalsenjak, I., Surface topography of microcapsules and the drug release. J. Pharm. Pharmacol., 33 (1981) 665-666.
35. Sevgi, F., Özyazici, M. and Güneri, T., Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: Microencapsulation and in vitro release kinetics. J. Microencapsulation, 11 (1994) 327-334.
36. Steiner, G., Patel. M. and Carstensen, J.T., Effect of milling on granulation particle-size distribution. J. Pharm. Sci., 63 (1974) 1395-1398.
37. Stockham, J.D. and Fochtman, E.G., Particle Size Analysis, Ann Arbor Science Publishers, Ann Arbor, MI, 1979.
38. Sunner, E.D., Thompson, H.O., Poole, W.K. and Grizzle. J.E.. Particle size distribution and hopper flow rates. J. Pharm. Sci., 55 (1966) 1441-1446.
39. Takenaka, H., Kawashima, Y. and Lin, S.Y., Micromeritic properties of sulfamethaxazole microcapsules prepared by gelatin-acacia coacervation. J. Pharm. Sci., 69 (1980) 513-516.
40. Merck, The Merck Index. 11th edn., Merck and Co. Inc., Rahway, 1989.
41. US Pharmacopeia XXII (USP XXII-NF XVII), Mack Publishing Company, Easton, 1990.
42. Torrado-Duran, J.J., Torrado-Valeiras, J.J. and Cadorniga, Y., Microaggregated egg albumin particles containing paracetamol for tableting process. Drug Dev. Ind. Pharm., 17 (1991) 1305-1323.
43. Voight, R. and Bornschein, M., Lehrbuch der Pharmazeutischen Technologie, Verlag Chemie, New York, 1982, pp. 157-167.
44. Wells, J.I., Pharmaceutical Preformulation: The Physicochemical Properties of Drug Substances, Wiley, New York, 1988, pp. 209-214.
45. Woodruff, C.W. and Nuessle. N.O., Effect of processing variables on particles obtained by extrusion-spheronization processing. J. Pharm. Sci., 61 (1972) 787-790.